Curcumin Complex

Curcumin Complex

$37.50
RV30C

Curcumin Complex is a practitioner-only listed medicine containing Curcuma longa fixed oil, curcumin and soy lecithin-derived phospholipids, including phosphatidyl choline. It is intended for qualified healthcare practitioners seeking curcumin-based support for inflammation relief and antioxidant activity.

60 x 1250 mg soft gel capsules | AUST L 525856

Each 1250 mg soft capsule contains:

Curcuma longa root fixed oil 450 mg

Curcumin 200 mg

Soy phosphatidylserine-enriched soy lecithin liquid 200 mg
Equivalent to phosphatidyl choline 40 mg
Equivalent to soy phosphatidylserine 1 mg

Contains soya bean products.

Curcumin Complex is formulated to:

  • relieve inflammation
  • provide antioxidant activity
  • help reduce free radicals formed in the body

Directions

Recommended practitioner dosage:

Take 1 capsule once or twice daily with food, or as directed by a qualified healthcare practitioner.

Dosage and duration should be determined by the treating healthcare practitioner based on individual assessment.

Warnings

Contains soya bean products.

Adults only.

In very rare cases, Curcuma species or Curcumin may harm the liver. Stop use and see a doctor if you have yellowing skin/eyes or unusual: fatigue, nausea, appetite loss, abdominal pain, dark urine, or itching.

If symptoms persist, talk to your health professional.

This section is provided for qualified healthcare practitioners as professional education. It summarises selected ingredient-level and pathway-level research relating to curcumin, Curcuma longa fixed oil, phospholipid delivery and antioxidant / inflammatory pathways. It does not represent additional ARTG indications for Curcumin Complex.

Curcumin Complex is relevant to practitioners interested in curcumin research, inflammatory pathway modulation, oxidative stress, antioxidant activity, cellular signalling and phospholipid-based delivery systems.

Curcumin has been widely discussed in professional literature in relation to inflammatory signalling, oxidative stress, antioxidant activity and cellular pathway research. This supports practitioner education around the product’s anti-inflammatory and antioxidant positioning.

Curcumin is also recognised for formulation challenges relating to absorption and bioavailability. Curcumin Complex combines curcumin with Curcuma longa fixed oil and soy lecithin-derived phospholipids, including phosphatidyl choline, which is relevant to practitioner education around lipid-based and phospholipid-associated curcumin delivery.

The formula’s curcumin and Curcuma longa fixed oil content supports practitioner interest in inflammation relief and antioxidant activity, while the soy phospholipid component supports discussion of delivery-system design and ingredient functionality.

Curcumin and Curcuma longa have also been studied in broader clinical and preclinical research settings, including gastrointestinal, metabolic, inflammatory, hepatic and oncology-related research. This information is provided for practitioner education only and should not be interpreted as a therapeutic indication for Curcumin Complex.

Practitioners should also be aware that medicinal turmeric and curcumin products have been associated with a rare risk of liver injury. This safety consideration is relevant when assessing suitability, duration of use and patient monitoring.

This information is provided for practitioner education only and does not represent additional ARTG indications for Curcumin Complex.

References available to registered practitioners on request.